Sophia Genetics, Inc.

Boston, MA Sophia Genetics Inc. Part of Sophia Genetics SA

UEI
NEMYM6948U93
CAGE
814V7
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
Landmark Center, 401 Park Dr #505, Boston, MA 02215, USA
Website
sophiagenetics.com
Founded
2011
Employees
251-1K
Estimated annual revenue
$50M-$100M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Sophia Genetics, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Bioinformatics services in support of keesler medical center. Contract · HT940825CE005 Defense Health Agency $1,119,200
Bioinformatics interpretation services Contract · HT940824C0007 Defense Health Agency $832,040
Bioinformatics services Contract · FA301023P0007 Air Education and Training Command $432,719
Sophia genetics alamut software licenses renewal Contract · 75N93022P00266 National Institute of Allergy and Infectious Diseases $14,574
Upgrades and maintenance of software Contract · 75N92E21P00229 National Human Genome Research Institute $10,367

About Sophia Genetics, Inc.

Sophia Genetics, Inc., a Boston-based subsidiary of a foreign-owned parent company, is a for-profit bioinformatics firm specializing in advanced genetic and genomic analysis services for federal research and medical institutions. The company provides specialized software platforms, genetic interpretation services, and database access that support clinical operations and genomic research across multiple federal agencies. Registered in SAM.gov since December 2017, Sophia Genetics has established itself as a reliable vendor for federal bioinformatics needs through consistent contract awards spanning multiple years and agencies.

Sophia Genetics' federal contract portfolio demonstrates extensive expertise in bioinformatics services across the Department of Defense and the National Institutes of Health. The company's largest recent award came from the Defense Health Agency in September 2025, a $3.36 million firm fixed-price definitive contract for bioinformatics services supporting Keesler Medical Center through September 2028. Prior to this, the Air Education and Training Command awarded the company two contracts: a $832,040 definitive contract in March 2024 for bioinformatics interpretation services at Keesler Air Force Base, and a $432,719 purchase order in February 2023 for bioinformatics services including software licenses, upgrades, maintenance, and database access. Additionally, Sophia Genetics received smaller purchase orders from the National Institute of Allergy and Infectious Diseases ($14,574 in January 2022 for Alamut software license renewal) and the National Human Genome Research Institute ($10,367 in July 2021 for software upgrades and maintenance). All of these awards were made through open competition with no small business set-asides, reflecting the company's ability to compete directly against other qualified vendors. The scope of services consistently includes bioinformatics interpretation, genetic analysis, exome sequencing testing, software licensing renewals, system upgrades, and maintenance support, positioning Sophia Genetics as a specialized provider of computational genomics solutions for federal medical and research operations.

SBA capabilities narrative

Sophia Genetics, Inc.

SOPHiA GENETICS combines deep expertise in life sciences and medical disciplines with mathematical capabilities in data computing.

Quick answers

What is Sophia Genetics, Inc.'s UEI?

Sophia Genetics, Inc.'s Unique Entity ID (UEI) in SAM.gov is NEMYM6948U93.

What is Sophia Genetics, Inc.'s CAGE code?

Sophia Genetics, Inc.'s CAGE code is 814V7.

What is Sophia Genetics, Inc.'s primary NAICS code?

Sophia Genetics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Sophia Genetics, Inc. located?

Sophia Genetics, Inc.'s physical address in SAM.gov is Landmark Center, 401 Park Dr #505, Boston, MA 02215, USA.

Is Sophia Genetics, Inc. registered in SAM.gov?

Yes. Sophia Genetics, Inc.'s SAM.gov registration is active through December 9, 2026.

Who is Sophia Genetics, Inc.'s parent company?

Sophia Genetics, Inc. is part of Sophia Genetics SA.

What is Sophia Genetics, Inc.'s most recent federal award?

Sophia Genetics, Inc.'s most recent federal contract award is Bioinformatics services in support of keesler medical center (HT940825CE005), from Defense Health Agency, on September 30, 2025.

On GovTribe

See Sophia Genetics, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors